Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis

Jonathan A C Sterne(University of Bristol), Aroon D. Hingorani(University College London Hospitals NHS Foundation Trust), Jelena Savović(University Hospitals Bristol NHS Foundation Trust), Chris Salisbury(University of Bristol), Julian P. T. Higgins(University of Bristol), Deborah M Caldwell(St. Michael's Hospital), Reecha Sofat(University College London), Nicky J. Welton(University of Bristol), Diane Eaton, José A López-López(Instituto Murciano de Investigación Biosanitaria), Sofia Dias, William Hollingworth(At Bristol), George N. Okoli(University of Bristol), Howard Thom(Clifton Hospital), Peter Bryden(University of Bristol), Annya Stephens-Boal(Thrombosis Research Institute), Pritesh Bodalia(University College London Hospitals NHS Foundation Trust), Philippa Davies(University of Bristol)
Health Technology Assessment
March 1, 2017
Cited by 202


Related Papers